Actively Recruiting

Age: 18Years +
All Genders
ID06401421

Clinical Validation Study of ctDNA to Predict Recurrence in High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy

Led by Exact Sciences Corporation · Updated on 2026-01-20

1800

Participants Needed

58

Research Sites

N/A

Total Duration

On this page

Sponsors

E

Exact Sciences Corporation

Lead Sponsor

N

NSABP Foundation Inc

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a method to detect molecular residual disease (MRD) in people with high-risk early breast cancer undergoing chemotherapy. This observational study aims to predict cancer recurrence by analyzing circulating tumor DNA (ctDNA) from blood and tissue samples. Participants will be followed for up to 5.5 years to better understand the presence of tumor DNA after treatment and its relation to cancer outcomes. The study involves collecting blood and tissue samples to perform a ctDNA MRD test. Participants must have a confirmed invasive breast cancer planned for neoadjuvant chemotherapy, with tumors 2.1 cm or larger and certain clinical subtypes or risk factors. Residual tissue from diagnostic biopsies will be used to create personalized ctDNA assays. No experimental treatment is given; instead, participants are observed to assess test accuracy and disease recurrence. During the study, participants will provide blood samples totaling 34 cc at research visits and submit available biopsy tissue. Researchers will evaluate tissue sample quality and track distant recurrence-free intervals over six years. Various outcomes such as tumor mutation prevalence, test sensitivity, survival rates, and time to recurrence will be measured. The study's long-term follow-up allows close monitoring of disease status and patient health.

CONDITIONS

Brief Title

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant or authorized representative provides informed consent.
  • Participant is 18 years of age or older.
  • ECOG performance status of 0 or 1.
  • Histologically confirmed invasive breast carcinoma.
  • Planned neoadjuvant therapy including cytotoxic chemotherapy.
  • Tumor size 2.1 cm or greater in greatest diameter.
  • Unifocal or multifocal cancer of the same histologic clinical subtype.
  • Clinically node positive, or if node negative, meets specific subtype or risk criteria including triple-negative, HER2+, or high-risk HR+/HER2-negative.
  • Willing and able to comply with study requirements, including blood collection.
  • Available residual tissue from diagnostic biopsy for ctDNA assay creation.
Not Eligible

You will not qualify if you...

  • Evidence of metastatic disease.
  • Started neoadjuvant therapy for current breast cancer.
  • Diagnosis of another invasive cancer at the same time, except non-melanoma skin cancer.
  • Completed therapy for previous invasive cancer less than 5 years ago, except noninvasive carcinomas with definitive treatment.
  • Completed therapy for prior hematologic malignancy less than 5 years ago.
  • Multicentric or contralateral invasive breast cancers.
  • Known pregnancy at enrollment.
  • Prior solid organ transplant.
  • Prior allogeneic hematopoietic stem cell transplant.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Initial assessment at enrollment

Participants provide blood and tissue samples for the ctDNA MRD test to assess molecular residual disease.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 6 years

Participants are monitored over several years to evaluate recurrence and survival outcomes.

Periodic visits over 6 years

Trial Site Locations

Total: 58 locations

1

Katmai Oncology Group - Anchorage

Anchorage, Alaska, United States, 99508

Actively Recruiting

2

Stanford Cancer Institute

Palo Alto, California, United States, 94304

Actively Recruiting

3

Harbor-UCLA Medical Center - Hematology / Oncology

Torrance, California, United States, 90502

Actively Recruiting

4

Kaiser Permanente Medical Center

Vallejo, California, United States, 94589

Actively Recruiting

5

UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center

Aurora, Colorado, United States, 80045

Actively Recruiting

6

AdventHealth East Altamonte Oncology and Hematology

Altamonte Springs, Florida, United States, 32701

Actively Recruiting

7

Mount Sinai Medical - Comprehensive Cancer Center

Miami Beach, Florida, United States, 33140

Actively Recruiting

8

Baptist Cancer Care - Plantation

Plantation, Florida, United States, 33324

Actively Recruiting

9

St. Joseph's Women's Hospital

Tampa, Florida, United States, 33607

Actively Recruiting

10

Rush Cancer Center

Chicago, Illinois, United States, 60607

Actively Recruiting

11

Deaconess Chancellor Center for Oncology

Newburgh, Indiana, United States, 47630

Actively Recruiting

12

University of Kansas Cancer Center

Westwood, Kansas, United States, 66205

Actively Recruiting

13

St. Elizabeth Edgewood Hospital

Edgewood, Kentucky, United States, 41017

Actively Recruiting

14

Norton Cancer Institute - Downtown

Louisville, Kentucky, United States, 40202

Actively Recruiting

15

Baptist Health Louisville

Louisville, Kentucky, United States, 40207

Actively Recruiting

16

Weinberg Center at Mercy

Baltimore, Maryland, United States, 21202

Actively Recruiting

17

Greater Baltimore Medical Center

Baltimore, Maryland, United States, 21204

Actively Recruiting

18

Sinai Hospital of Baltimore

Baltimore, Maryland, United States, 21215

Actively Recruiting

19

MedStar Georgetown Cancer Institute

Baltimore, Maryland, United States, 21237

Actively Recruiting

20

The Center for Cancer and Blood Disorders - Bethesda

Bethesda, Maryland, United States, 20818

Actively Recruiting

21

James M Stockman Cancer Institute

Frederick, Maryland, United States, 21702

Actively Recruiting

22

Tate Cancer Center at UM Baltimore Washington

Glen Burnie, Maryland, United States, 21061

Actively Recruiting

23

Meritus Center for Clinical Research

Hagerstown, Maryland, United States, 21742

Actively Recruiting

24

Holy Cross Hospital - Silver Spring

Silver Spring, Maryland, United States, 20910

Actively Recruiting

25

University of Maryland St. Joseph Medical Center

Towson, Maryland, United States, 21204

Actively Recruiting

26

Lahey Hospital & Medical Center

Burlington, Massachusetts, United States, 01805

Actively Recruiting

27

Metro Minnesota Community Oncology Consortium (MMCORC)

Saint Louis Park, Minnesota, United States, 55426

Actively Recruiting

28

Saint Luke's Hospital of Kansas City

Kansas City, Missouri, United States, 64111

Actively Recruiting

29

John Theurer Cancer Center

Hackensack, New Jersey, United States, 07601

Actively Recruiting

30

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08901

Actively Recruiting

31

Stony Brook Medicine

Stony Brook, New York, United States, 11794

Actively Recruiting

32

Atrium Health Levine Cancer Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

33

Novant Health Cancer Institute - Elizabeth

Charlotte, North Carolina, United States, 28204

Actively Recruiting

34

FirstHealth Outpatient Cancer Center

Pinehurst, North Carolina, United States, 28374

Actively Recruiting

35

UNC Cancer Care at Nash

Rocky Mount, North Carolina, United States, 27804

Actively Recruiting

36

Atrium Health Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

37

Aultman Timken Family Cancer Center

Canton, Ohio, United States, 44710

Actively Recruiting

38

Cleveland Clinic Main Campus

Cleveland, Ohio, United States, 44195

Actively Recruiting

39

Penn State Health Medical Group - Andrews Patel

Harrisburg, Pennsylvania, United States, 17111

Actively Recruiting

40

Penn State Cancer Institute

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

41

UPMC Magee - Womens Hospital

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

42

Guthrie Sayre

Sayre, Pennsylvania, United States, 18840

Actively Recruiting

43

Women & Infants Hospital

Providence, Rhode Island, United States, 02905

Actively Recruiting

44

Spartanburg Medical Center

Spartanburg, South Carolina, United States, 29303

Actively Recruiting

45

Avera Cancer Institute

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

46

Ballad Health Cancer Center

Kingsport, Tennessee, United States, 37660

Actively Recruiting

47

The University of Texas MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

48

Joe Arrington Cancer Research & Treatment Center

Lubbock, Texas, United States, 79410

Actively Recruiting

49

Alan B. Pearson Regional Cancer Center

Lynchburg, Virginia, United States, 24501

Actively Recruiting

50

Bon Secours Cancer Institute at St. Francis

Midlothian, Virginia, United States, 23114

Actively Recruiting

51

VCU Massey Comprehensive Cancer Center

Richmond, Virginia, United States, 23298

Actively Recruiting

52

WVU Cancer Institute

Morgantown, West Virginia, United States, 26505

Actively Recruiting

53

Aurora Cancer Care - Wauwatosa

Wauwatosa, Wisconsin, United States, 53226

Actively Recruiting

54

Maisonneuve-Rosemont Hospital (HMR)

Montreal, Quebec, Canada, H1T 2M4

Actively Recruiting

55

Centre Hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada, H2X 3E4

Actively Recruiting

56

Jewish General Hospital

Montreal, Quebec, Canada, H3T1E2

Actively Recruiting

57

McGill University Health - Glen Site

Montreal, Quebec, Canada

Actively Recruiting

58

Hôpital du Saint-Sacrement

Québec, Quebec, Canada, G1S 4L8

Actively Recruiting

Loading map...

Research Team

N

NSABP Department of Site and Study Management Department of Site and Study Management

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here